- Published on
Diagnostic Tests: Right Upper Quadrant (RUQ) Ultrasound
Clinical Scenarios Where RUQ Ultrasound Is the Correct Answer
A right upper quadrant ultrasound is the first-line imaging test when a patient presents with right upper quadrant abdominal pain, with or without fever. It is specifically designed to evaluate the hepatobiliary system and is highly effective for identifying both liver and biliary tract pathology. RUQ ultrasound is appropriate when assessing:
Most Accurate Diagnostic Tests
While RUQ ultrasound is the best initial test, the most accurate diagnostic tests depend on the suspected pathology:
Significance of Pain During RUQ Ultrasound
If the patient experiences marked tenderness when the ultrasound transducer presses over the gallbladder, this finding is known as a positive Murphy’s sign. A sonographic Murphy’s sign is highly suggestive of acute cholecystitis, especially when accompanied by gallstones, gallbladder wall thickening, or pericholecystic fluid on ultrasound.
Clinical Scenarios Where RUQ Ultrasound Is the Correct Answer
A right upper quadrant ultrasound is the first-line imaging test when a patient presents with right upper quadrant abdominal pain, with or without fever. It is specifically designed to evaluate the hepatobiliary system and is highly effective for identifying both liver and biliary tract pathology. RUQ ultrasound is appropriate when assessing:
- Liver pathology, including:
- Hepatic masses (tumors, abscesses, cysts)
- Evidence of portal hypertension
- Gallbladder and biliary tree disorders, such as:
- Cholelithiasis
- Acute or chronic cholecystitis
- Choledocholithiasis
- Cholangitis
Most Accurate Diagnostic Tests
While RUQ ultrasound is the best initial test, the most accurate diagnostic tests depend on the suspected pathology:
- Biliary pathology (stones, obstruction, cholangitis):
- ERCP (Endoscopic Retrograde Cholangiopancreatography)
- MRCP (Magnetic Resonance Cholangiopancreatography)
- Liver pathology (tumors, diffuse liver disease):
- Liver biopsy is the most accurate test
Significance of Pain During RUQ Ultrasound
If the patient experiences marked tenderness when the ultrasound transducer presses over the gallbladder, this finding is known as a positive Murphy’s sign. A sonographic Murphy’s sign is highly suggestive of acute cholecystitis, especially when accompanied by gallstones, gallbladder wall thickening, or pericholecystic fluid on ultrasound.
- Published on
Diagnostic Tests: Renal Ultrasound
Overview — Clinical Conditions Commonly Evaluate
Renal ultrasound is a noninvasive imaging study that uses sound waves to visualize the kidneys and surrounding structures. It does not require contrast and exposes the patient to no radiation, making it especially useful as a first-line test in many renal and urinary conditions. Renal ultrasound is commonly used in the evaluation of:
Because it is safe, quick, and widely available, renal ultrasound is often preferred as the initial imaging modality.
When Renal Ultrasound Is the Correct Answer
You should answer renal ultrasound in clinical scenarios involving unexplained urinary or flank symptoms, particularly when structural disease or obstruction is suspected. Typical situations include:
Overview — Clinical Conditions Commonly Evaluate
Renal ultrasound is a noninvasive imaging study that uses sound waves to visualize the kidneys and surrounding structures. It does not require contrast and exposes the patient to no radiation, making it especially useful as a first-line test in many renal and urinary conditions. Renal ultrasound is commonly used in the evaluation of:
- Kidney stones (to detect hydronephrosis from obstruction)
- Congenital renal malformations
- Pediatric renal tumors
- Recurrent urinary tract infections
- Chronic renal failure (to assess kidney size and chronicity)
- Renal artery stenosis (with Doppler studies)
- Polycystic kidney disease
Because it is safe, quick, and widely available, renal ultrasound is often preferred as the initial imaging modality.
When Renal Ultrasound Is the Correct Answer
You should answer renal ultrasound in clinical scenarios involving unexplained urinary or flank symptoms, particularly when structural disease or obstruction is suspected. Typical situations include:
- Unexplained hematuria, especially when associated with flank pain or tenderness
- Flank pain suggestive of renal obstruction or infection
- Dysuric symptoms (frequency, burning with urination) accompanied by:
- White blood cells on urinalysis
- Flank pain, raising concern for upper urinary tract involvement (e.g., pyelonephritis or obstruction)
- Published on
Diagnostic Tests: Intravenous Pyelogram (IVP)
Overview — Clinical Context for IVP
An intravenous pyelogram (IVP) is a historical imaging test that involved injecting intravenous contrast followed by a series of X-rays to visualize the renal collecting system, including the calyces, renal pelvis, and ureters. Although it was once used to evaluate renal colic, especially when no stones were visible on plain radiographs, IVP has little to no role in modern clinical practice and is almost always an incorrect answer on exams.
Because the test is slow, requires contrast, and provides limited information compared with modern imaging, it has largely been abandoned.
Most Accurate and Preferred Tests Today
IVP has been replaced by safer and more effective imaging modalities:
Because IVP uses contrast, it carries risks of contrast-induced nephropathy and allergic reactions, making it inferior to CT and ultrasound.
Key Exam Pearl
If ultrasound or CT scan appears as an answer choice, IVP is never the correct answer. On exams, IVP is typically included as a distractor rather than the best diagnostic option.
Overview — Clinical Context for IVP
An intravenous pyelogram (IVP) is a historical imaging test that involved injecting intravenous contrast followed by a series of X-rays to visualize the renal collecting system, including the calyces, renal pelvis, and ureters. Although it was once used to evaluate renal colic, especially when no stones were visible on plain radiographs, IVP has little to no role in modern clinical practice and is almost always an incorrect answer on exams.
Because the test is slow, requires contrast, and provides limited information compared with modern imaging, it has largely been abandoned.
Most Accurate and Preferred Tests Today
IVP has been replaced by safer and more effective imaging modalities:
- Renal ultrasound
- Best initial test for suspected renal colic
- No radiation or contrast
- Especially useful in pregnancy or patients with renal insufficiency
- Non-contrast CT scan of the abdomen and pelvis
- Most accurate test for detecting kidney stones
- Fast, highly sensitive and specific
- Does not require contrast when evaluating for stones
Because IVP uses contrast, it carries risks of contrast-induced nephropathy and allergic reactions, making it inferior to CT and ultrasound.
Key Exam Pearl
If ultrasound or CT scan appears as an answer choice, IVP is never the correct answer. On exams, IVP is typically included as a distractor rather than the best diagnostic option.
- Published on
Diagnostic Tests: Cystography (Voiding Cystography / Voiding Cystourethrography)
Overview — What This Test Is
Cystography, also known as voiding cystography or voiding cystourethrography (VCUG), is a radiographic imaging study used to visualize the bladder and urethra during filling and emptying. Contrast material is instilled into the bladder through a catheter, and X-ray images are obtained as the bladder fills and during voiding. This test evaluates the anatomy and integrity of the lower urinary tract, particularly the bladder and urethra.
It is important not to confuse cystography with cystometrics, which measures bladder pressures and is used primarily to evaluate urinary incontinence. Cystography assesses structure and reflux, not pressure.
When to Choose Cystography
Cystography is the correct diagnostic study in several clinical scenarios where structural abnormalities or reflux are suspected. These include:
Bladder Trauma
- Suspected bladder rupture following pelvic or abdominal trauma
Neoplasia
- Evaluation of tumors in or around the bladder
Urinary Tract Infections in Children
Cystography is particularly important in pediatric UTI evaluation to detect vesicoureteral reflux (VUR). Indications include:
- All children younger than 5 years old with a UTI
- Children of any age with febrile UTI
- All boys, regardless of age, with a UTI
These populations have a higher risk of underlying anatomic abnormalities that predispose them to recurrent infections and renal damage.
- Published on
Diagnostic Tests: Bleeding Time
Overview
Bleeding time is a traditional test that evaluates the function of platelets, specifically their ability to adhere to damaged endothelium and form the initial platelet plug. It does not measure coagulation factors and should not be used when the platelet count is low, because anyone with thrombocytopenia will automatically have a prolonged bleeding time. Instead, bleeding time is helpful only when platelet number is normal but platelet function is suspected to be abnormal.
How the Test Is Performed
To perform the bleeding time test, a blood pressure cuff is inflated to 40 mmHg to standardize vascular pressure and engorge capillaries. Small standardized cuts are then made in the skin, and the time required for bleeding to stop is measured. A prolonged bleeding time indicates impaired platelet adhesion or aggregation.
When Bleeding Time Is the Correct Answer
Bleeding time is chosen when a patient has abnormal bleeding suggestive of a platelet disorder, but the platelet count is normal. These clinical scenarios involve qualitative platelet dysfunction, not a quantitative deficiency. Classic examples include:
These conditions impair platelet function even though platelet numbers remain normal. Thus, a prolonged bleeding time supports the suspicion of a functional platelet abnormality.
Most Accurate Tests
Although bleeding time can suggest platelet dysfunction, it is not the most accurate test for diagnosing specific disorders. More precise evaluations include:
These tests provide definitive diagnostic information for platelet-type bleeding disorders, particularly von Willebrand disease.
Overview
Bleeding time is a traditional test that evaluates the function of platelets, specifically their ability to adhere to damaged endothelium and form the initial platelet plug. It does not measure coagulation factors and should not be used when the platelet count is low, because anyone with thrombocytopenia will automatically have a prolonged bleeding time. Instead, bleeding time is helpful only when platelet number is normal but platelet function is suspected to be abnormal.
How the Test Is Performed
To perform the bleeding time test, a blood pressure cuff is inflated to 40 mmHg to standardize vascular pressure and engorge capillaries. Small standardized cuts are then made in the skin, and the time required for bleeding to stop is measured. A prolonged bleeding time indicates impaired platelet adhesion or aggregation.
When Bleeding Time Is the Correct Answer
Bleeding time is chosen when a patient has abnormal bleeding suggestive of a platelet disorder, but the platelet count is normal. These clinical scenarios involve qualitative platelet dysfunction, not a quantitative deficiency. Classic examples include:
- Von Willebrand disease
- Uremia-induced platelet dysfunction
These conditions impair platelet function even though platelet numbers remain normal. Thus, a prolonged bleeding time supports the suspicion of a functional platelet abnormality.
Most Accurate Tests
Although bleeding time can suggest platelet dysfunction, it is not the most accurate test for diagnosing specific disorders. More precise evaluations include:
- Von Willebrand factor level
- Ristocetin cofactor assay (tests VWF function)
- In vitro platelet aggregation studies (directly assess platelet function)
These tests provide definitive diagnostic information for platelet-type bleeding disorders, particularly von Willebrand disease.
- Published on
Diagnostic Tests: Anti–Intrinsic Factor Antibodies & Antiparietal Cell Antibodies
Overview
Anti–intrinsic factor (anti-IF) antibodies and antiparietal cell antibodies are highly specific markers used to confirm the diagnosis of pernicious anemia, an autoimmune cause of vitamin B₁₂ deficiency. In pernicious anemia, the immune system attacks either intrinsic factor itself or the gastric parietal cells that produce intrinsic factor and gastric acid. Because vitamin B₁₂ cannot be absorbed without intrinsic factor, autoimmune destruction leads to severe B₁₂ deficiency over time. Anti-intrinsic factor antibodies are nearly 100% specific for pernicious anemia, while antiparietal cell antibodies support the diagnosis but are less specific, as they can also appear in autoimmune gastritis.
When These Antibody Tests Are Used
These antibody tests are ordered after confirming vitamin B₁₂ deficiency, to determine its underlying cause. You should select anti-IF and antiparietal cell antibody testing when evaluating a patient with confirmed B₁₂ deficiency—either through low serum B₁₂ levels or elevated methylmalonic acid—and you need to clarify whether the etiology is pernicious anemia. The clinical scenario usually includes macrocytic anemia, neurologic symptoms, glossitis, or long-standing nutritional deficiency concerns. These antibodies are not used to diagnose B₁₂ deficiency itself, but rather to establish why the deficiency occurred when pernicious anemia is suspected.
Overview
Anti–intrinsic factor (anti-IF) antibodies and antiparietal cell antibodies are highly specific markers used to confirm the diagnosis of pernicious anemia, an autoimmune cause of vitamin B₁₂ deficiency. In pernicious anemia, the immune system attacks either intrinsic factor itself or the gastric parietal cells that produce intrinsic factor and gastric acid. Because vitamin B₁₂ cannot be absorbed without intrinsic factor, autoimmune destruction leads to severe B₁₂ deficiency over time. Anti-intrinsic factor antibodies are nearly 100% specific for pernicious anemia, while antiparietal cell antibodies support the diagnosis but are less specific, as they can also appear in autoimmune gastritis.
When These Antibody Tests Are Used
These antibody tests are ordered after confirming vitamin B₁₂ deficiency, to determine its underlying cause. You should select anti-IF and antiparietal cell antibody testing when evaluating a patient with confirmed B₁₂ deficiency—either through low serum B₁₂ levels or elevated methylmalonic acid—and you need to clarify whether the etiology is pernicious anemia. The clinical scenario usually includes macrocytic anemia, neurologic symptoms, glossitis, or long-standing nutritional deficiency concerns. These antibodies are not used to diagnose B₁₂ deficiency itself, but rather to establish why the deficiency occurred when pernicious anemia is suspected.
- Published on
Diagnostic Tests: Ristocetin Cofactor Assay
Overview — What This Test Is
The Ristocetin Cofactor Assay is a laboratory test that evaluates the functional activity of von Willebrand factor (VWF).
Ristocetin acts as a surrogate for the endothelial surface, promoting VWF-mediated platelet agglutination. When VWF is present and functioning normally, platelets will clump in response to ristocetin.
This assay, together with a VWF antigen level, is considered one of the most accurate tests for diagnosing von Willebrand disease (vWD).
When This Is the Correct Answer
Choose the Ristocetin Cofactor Assay when a patient presents with:
This pattern suggests qualitative VWF defects, particularly Type 2 von Willebrand disease, where VWF quantity may be normal but function is impaired.
The ristocetin assay detects impaired VWF-mediated platelet adhesion, helping distinguish between quantitative and qualitative defects.
Overview — What This Test Is
The Ristocetin Cofactor Assay is a laboratory test that evaluates the functional activity of von Willebrand factor (VWF).
Ristocetin acts as a surrogate for the endothelial surface, promoting VWF-mediated platelet agglutination. When VWF is present and functioning normally, platelets will clump in response to ristocetin.
This assay, together with a VWF antigen level, is considered one of the most accurate tests for diagnosing von Willebrand disease (vWD).
When This Is the Correct Answer
Choose the Ristocetin Cofactor Assay when a patient presents with:
- Platelet-type bleeding, such as:
- Epistaxis
- Petechiae
- Purpura
- Gum bleeding or gingival bleeding
- Normal platelet count
- Normal VWF level, but clinical suspicion for vWD remains
(e.g., VWF is present but non-functional)
This pattern suggests qualitative VWF defects, particularly Type 2 von Willebrand disease, where VWF quantity may be normal but function is impaired.
The ristocetin assay detects impaired VWF-mediated platelet adhesion, helping distinguish between quantitative and qualitative defects.
- Published on
Diagnostics Tests: Russell’s Viper Venom Clotting Time (RVVT)
Overview — What RVVT Is
Russell’s Viper Venom Clotting Time (RVVT) is a phospholipid-dependent coagulation test used to evaluate abnormalities in the clotting cascade.
The venom directly activates factor X, bypassing most of the intrinsic pathway. Because the test depends on phospholipids, it becomes prolonged when antiphospholipid antibodies interfere with the reaction.
A specialized form, the dilute Russell viper venom test (dRVVT), is used to increase sensitivity for lupus anticoagulant detection.
When RVVT Is Indicated
RVVT is used primarily in the detection of antiphospholipid antibodies, especially the lupus anticoagulant.
You should think of this test when:
RVVT is more specific than traditional PTT testing for diagnosing lupus anticoagulant.
Common Clinical Scenario
A typical clinical vignette that points toward lupus anticoagulant and therefore RVVT includes:
Overview — What RVVT Is
Russell’s Viper Venom Clotting Time (RVVT) is a phospholipid-dependent coagulation test used to evaluate abnormalities in the clotting cascade.
The venom directly activates factor X, bypassing most of the intrinsic pathway. Because the test depends on phospholipids, it becomes prolonged when antiphospholipid antibodies interfere with the reaction.
A specialized form, the dilute Russell viper venom test (dRVVT), is used to increase sensitivity for lupus anticoagulant detection.
When RVVT Is Indicated
RVVT is used primarily in the detection of antiphospholipid antibodies, especially the lupus anticoagulant.
You should think of this test when:
- A patient has a prolonged PTT
- The PTT does not correct with a mixing study (suggesting an inhibitor rather than a factor deficiency)
- You need confirmation that the inhibitor is specifically a lupus anticoagulant
RVVT is more specific than traditional PTT testing for diagnosing lupus anticoagulant.
Common Clinical Scenario
A typical clinical vignette that points toward lupus anticoagulant and therefore RVVT includes:
- A woman, often of childbearing age
- With or without known systemic lupus erythematosus (SLE)
- Recurrent spontaneous abortions (classic high-yield clue)
- History of unexplained venous or arterial thrombosis, such as:
- Deep vein thrombosis
- Pulmonary embolism
- Stroke in a young patient
- Or delivering an infant with congenital heart block (neonatal lupus can occur from anti-Ro/SSA, often coexisting with antiphospholipid antibodies)
- Published on
Diagnostic Tests: Schilling Test
Overview — Clinical Conditions for Which the Schilling Test Is Used
The Schilling test is a historical diagnostic test used to determine the cause of vitamin B₁₂ (cobalamin) deficiency.
Although rarely used today, it is a classic board-style question.
The most common cause of B₁₂ deficiency is pernicious anemia, which results from autoantibodies against intrinsic factor (IF) or against parietal cells that produce IF.
The Schilling test helps differentiate:
How the Schilling Test Is Performed
The Schilling test is performed in stages:
Stage 1
Stage 2
The test is repeated, this time with oral intrinsic factor added to the radiolabeled B₁₂.
Interpretation:
Schilling’s test is rarely the correct answer today, but in board-style questions you choose it when:
In other words, use the Schilling test only when the cause of B₁₂ deficiency is unknown and pernicious anemia has not been confirmed by simpler tests.
If you’d like, I can provide a comparison of B₁₂ deficiency vs. folate deficiency, or a simple diagnostic algorithm for evaluating macrocytic anemia.
Overview — Clinical Conditions for Which the Schilling Test Is Used
The Schilling test is a historical diagnostic test used to determine the cause of vitamin B₁₂ (cobalamin) deficiency.
Although rarely used today, it is a classic board-style question.
The most common cause of B₁₂ deficiency is pernicious anemia, which results from autoantibodies against intrinsic factor (IF) or against parietal cells that produce IF.
The Schilling test helps differentiate:
- Pernicious anemia (intrinsic factor deficiency)
from - Intestinal malabsorption of B₁₂
- Other causes of poor cobalamin absorption
How the Schilling Test Is Performed
The Schilling test is performed in stages:
Stage 1
- Oral dose of radiolabeled vitamin B₁₂ (cyanocobalamin) is given.
- Intramuscular injection of unlabeled B₁₂ is given 1 hour later to saturate binding sites and ensure radiolabeled B₁₂ is excreted in the urine if absorbed normally.
- Urine is collected for 24 hours to measure the percentage of radiolabeled B₁₂ excreted.
- Low urinary excretion → indicates poor absorption of B₁₂
Stage 2
The test is repeated, this time with oral intrinsic factor added to the radiolabeled B₁₂.
Interpretation:
- Urinary excretion normalizes → Pernicious anemia (lack of intrinsic factor).
- Urinary excretion remains low → intestinal malabsorption (e.g., ileal disease, bacterial overgrowth, pancreatic insufficiency).
Schilling’s test is rarely the correct answer today, but in board-style questions you choose it when:
- The patient clearly has vitamin B₁₂ deficiency, and
- Tests for intrinsic factor antibodies and parietal cell antibodies are negative, and
- The etiology is still unclear, or
- The antibody tests are not available among the answer choices
In other words, use the Schilling test only when the cause of B₁₂ deficiency is unknown and pernicious anemia has not been confirmed by simpler tests.
If you’d like, I can provide a comparison of B₁₂ deficiency vs. folate deficiency, or a simple diagnostic algorithm for evaluating macrocytic anemia.
- Published on
Diagnostic Tests: Serum Protein Electrophoresis (SPEP)
Overview — What SPEP Is?
Serum protein electrophoresis (SPEP) is a laboratory test that separates and quantifies the major protein components of the blood. By applying an electric current to serum, proteins migrate based on their size and charge, producing a pattern that distinguishes:
- Albumin
- α1, α2, β, and γ globulin fractions
- Immunoglobulins (IgG, IgA, IgM, etc.)
This allows clinicians to identify abnormal elevations—especially monoclonal spikes (“M-spikes”) that suggest plasma cell disorders.
When SPEP Is the Correct Answer
Choose SPEP when evaluating:
- Elevated total serum protein
- Unexplained anemia, especially with rouleaux formation
- Bone pain or lytic lesions on X-ray
- Renal failure of unclear origin
- Symptoms suggestive of plasma cell dyscrasias (fatigue, weight loss, recurrent infections)
SPEP is the best initial test to diagnose multiple myeloma, particularly when:
- X-rays for lytic lesions have already been performed
- Or when imaging is not an available answer choice
Most Common Reason for an Abnormal SPEP
The most common cause of an abnormal SPEP—particularly a monoclonal spike—is:
Monoclonal Gammopathy of Unknown/Undetermined Significance (MGUS)
MGUS is far more common than multiple myeloma and is often asymptomatic, although it requires monitoring due to its risk of progression.
Most Accurate Diagnostic Test
For confirming an IgG monoclonal abnormality detected on SPEP, the most accurate test is:
Bone Marrow Biopsy
Findings diagnostic of multiple myeloma include:
- >10% clonal plasma cells
- Evidence of organ damage (CRAB criteria: hyperCalcemia, Renal failure, Anemia, Bone lesions)
If you’d like, I can produce a quick comparison table: SPEP vs. UPEP vs. Immunofixation, or a high-yield myeloma diagnostic algorithm.